However, a major federal initiative could change this in 2027: CMS BALANCE Model: GLP-1 Coverage Expansion On December 23, 2025, CMS announced the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth)a voluntary program that would cover GLP-1s for weight loss through participating Medicare Part D and Medicaid plans
Since starting NAD+, I have more energy and motivation to get through the day
GLP-1 medications are designed for subcutaneous fat, not muscle
Tirzepatide is called a dual-agonist, because it activates two receptors
Concurrently, we observed that after the activation of GLP-1 neurons, obese rats exhibited a significant reduction in food intake within 24 h (Fig
injections initially to rapidly replenish stores